Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$22 Mln
P/E Ratio
--
P/B Ratio
--
Industry P/E
--
Debt to Equity
--
ROE
--
ROCE
--
Div. Yield
--
Book Value
--
EPS
--
CFO
$-241.84 Mln
EBITDA
$-306.87 Mln
Net Profit
$-292.38 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Lisata Therapeutics Inc (LSTA)
| -17.83 | 4.20 | -8.63 | -7.52 | -34.08 | -39.89 | -40.51 |
|
BSE Sensex
| 2.61 | 3.71 | 5.78 | 8.89 | 11.76 | 20.11 | 11.35 |
|
2024
|
2023
|
|
|---|---|---|
|
Lisata Therapeutics Inc (LSTA)
| 9.08 | 7.91 |
|
BSE Sensex
| 8.10 | 18.74 |
|
BSE Sensex
| 8.10 | 18.74 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is in Phase... 2 clinical studies for the treatment of solid tumor, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, colon cancer and glioblastoma multiforme, in combination with a range of anti-cancer regimens. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey. Address: 110 Allen Road, Basking Ridge, NJ, United States, 07920 Read more
President, CEO & Director
Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D.
President, CEO & Director
Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D.
Headquarters
Basking Ridge, NJ
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Lisata Therapeutics Inc (LSTA) is $2.45 (NASDAQ) as of 29-Apr-2025 16:00 EDT. Lisata Therapeutics Inc (LSTA) has given a return of -34.08% in the last 3 years.
Lisata Therapeutics Inc (LSTA) has a market capitalisation of $ 22 Mln as on 28-Apr-2025. As per Value Research classification, it is a company.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Lisata Therapeutics Inc (LSTA) and enter the required number of quantities and click on buy to purchase the shares of Lisata Therapeutics Inc (LSTA).
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is in Phase 2 clinical studies for the treatment of solid tumor, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, colon cancer and glioblastoma multiforme, in combination with a range of anti-cancer regimens. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey. Address: 110 Allen Road, Basking Ridge, NJ, United States, 07920
The CEO & director of Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D.. is Lisata Therapeutics Inc (LSTA), and CFO & Sr. VP is Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D..
There is no promoter pledging in Lisata Therapeutics Inc (LSTA).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|
| Lisata Therapeutics Inc. (LSTA) | Ratios |
|---|---|
|
Return on equity(%)
|
--
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
--
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Lisata Therapeutics Inc (LSTA) was $0 Mln.
$-0.08
(
